A systematic review of national immunization policy making processes

Vaccine

Volumn 28, Issue SUPPL. 1, 2010, Pages

  Bryson, Maggie ^a   Duclos, Philippe ^b   Jolly, Ann ^a,c   Bryson, Jessica ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Immunization policy; Systematic review; Vaccine policy

Indexed keywords

ADVISORY COMMITTEE; ARTICLE; DATA SYNTHESIS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; IMMUNIZATION; INFORMATION RETRIEVAL; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; NATIONAL HEALTH ORGANIZATION; POLITICAL PARTICIPATION; PRIORITY JOURNAL; WEB BROWSER; WORLD HEALTH ORGANIZATION;

ADVISORY COMMITTEES; EVIDENCE-BASED MEDICINE; HEALTH POLICY; IMMUNIZATION; INTERNATIONALITY; POLICY MAKING;

EID: 77950909898     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.026     Document Type: Article

References (39)

1. World Health Organization. National immunization technical advisory group (ITAG): guidance for their establishment and functioning (2008). http://www.who.int/immunization/sage/National_TAG_guidelines_updated_21_Jul_09.pdf [accessed 05.02.10]
2. World Health Organization. Countries (2008). http://www.who.int/countries/en/index.html [accessed 05.02.10]
3. The University of Michigan. Foreign government resources on the web (2007). http://www.lib.umich.edu/govdocs/foreign.html [accessed 05.02.10]
4. Google. Google Canada (2008). http://www.google.ca/ [accessed 05.02.10]
5. Cunha S.C., and Dourado I. MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil. Health Policy 67 3 (2004) 323-328
6. O'Hallahan J., Lennon D., and Oster P. The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr Infect Dis J 23 12 (2004) 293-298
7. Munira S.L., and Fritzen S.A. What influences government adoption of vaccines in developing countries? A policy process analysis. Soc Sci Med 65 8 (2007) 1751-1764
8. Soeung S., Grundy J., Kamara L., McArthur A., and Samnang C. Developments in immunization planning in Cambodia-rethinking the culture and organization of national program planning. Rural Remote Health 7 April-June (2) (2007) 630-642
9. Sow S.O., Diallo S., Campbell J.D., Tapia M.D., Keita T., Keita M.M., et al. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Pediatr Infect Dis J 24 June (6) (2005) 533-537
10. Welte R., Trotter C.L., Edmunds W.J., Postma M.J., and Beutels P. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics 23 9 (2005) 855-874
11. Welte R., van den Dobbelsteen G., Bos J.M., de Melker H., van Alphen L., Spanjaard L., et al. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine 23 December (4) (2004) 470-479
12. Wisloff T., Abrahamsen T.G., Bergsaker M.A., Lovoll O., Moller P., Pedersen M.K., et al. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program. Vaccine 24 July (29-30) (2006) 5690-5699
13. The National Centre for Immunisation Research. National centre for immunisation research and surveillance of vaccine preventable diseases. Commun Dis Intell 28 1 (2004) 92-95
14. Blume S., and Zanders M. Vaccine independence, local competences and globalisation: lessons from the history of pertussis vaccines. Soc Sci Med 63 October (7) (2006) 1825-1835
15. Cowan S.A. Denmark decides not to introduce hepatitis B into the childhood vaccination programme. Eur Surveill 10 11 (2005) E051103.3
16. Dempsey A.F., Cowan A.E., Stokley S., Messonnier M., Clark S.J., and Davis M.M. The role of economic information in decision-making by the Advisory Committee on Immunization Practices. Vaccine 26 (2009) 5389-5392
17. Freed G.L. The structure and function of immunization advisory committees in Western Europe. Hum Vaccine 4 4 (2008) 292-297
18. Freed G.L., Pathman D.E., Konrad T.R., Freemand V.A., and Clark S.J. Adopting immunization recommendations: a new dissemination model. Matern Child Health J 2 December (4) (1998) 231-239
19. Gentile A. The need for an evidence-based decision-making process with regard to control of hepatitis A. J Viral Hepat 15 Suppl.2 (2008) 16-21
20. King L.A., Levy-Bruhl D., O'Flanagan D., Bacci S., Lopalco P.L., Kudjawu Y., et al. VENICE country specific gate keepers and contact points. Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: results of the VENICE 2007 survey. Eur Surveill 13 33 (2008) pii=18954
21. Maciosek M.V., Coffield A.B., Edwards N.M., Flottemesch T.J., Goodman M.J., and Solberg L.I. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31 July (1) (2006) 52-61
22. Milstien J., Cash R.A., Wecker J., and Wikler D. Development of priority vaccines for disease-endemic countries: risk and benefit. Health Aff 24 May-June (3) (2005) 718-728
23. Roughead E.E., Gilbert A.L., and Vitry A.I. The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy. Health Policy 88 (2008) 250-257
24. Salisbury D.M. Development of immunization policy and its implementation in the United Kingdom. Health Aff 24 May-June (3) (2005) 744-754
25. Smith J.C., Snider D.E., and Pickering L.K. Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices. Ann Intern Med 250 (2009) 45-49
26. Terebuh P., Uyeki T., and Fukuda K. Impact of influenza on young children and the shaping of United States influenza vaccine policy. Pediatr Infect Dis J 22 October (10 Suppl.) (2003) S231-S235
27. DeRoeck D., Clemens J.D., Nyamete A., and Mahoney R.T. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23 21 (2005) 2762-2774
28. Duke T. Slow but steady progress in child health in Papua New Guinea. J Paediatr Child Health 40 12 (2004) 659-663
29. Offit P.A., and Peter G. The meningococcal vaccine-public policy and individual choices. N Engl J Med 349 24 (2003) 2353-2356
30. Reid S. Evolution of the New Zealand childhood immunisation schedule from 1980: a personal view. N Z Med J 119 1236 (2006) 2035-2045
31. Erickson L.J., De Wals P., and Farand L. An analytical framework for immunization programs in Canada. Vaccine 23 19 (2005) 2470-2476
32. Freed G. Final report: analyzing vaccine programs/policies in Western Europe. Ann Arbour, MI: Child Health Evaluation and Research Unit, University of Michigan; 2007.
33. Australian Government. Department of Health and Ageing. Australian technical advisory group on immunisation (ATAGI), ; 2008 [accessed 05.02.10].
34. Public Health Agency of Canada. National advisory committee on immunization (NACI), ; 2008 [accessed 05.02.10].
35. New Zealand Ministry of Health. Immunisation-New Zealand immunisation schedule, ; 2008 [accessed 05.02.10].
36. Department of Health. Joint committee on vaccination and immunisation, ; 2002 [accessed 05.02.10].
37. Centers for Disease Control and Prevention. Vaccines & immunizations-recommendations and guidelines: Advisory Committee on Immunization Practices (ACIP) (2008). http://www.cdc.gov/vaccines/recs/acip/default.htm [accessed 05.02.10]
38. National Advisory Committee on Immunization. Evidence-based recommendations for immunization-Methods of the National Advisory Committee on Immunization. CCDR 35 January (2009) 1-10. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/acs-1/index-eng.php 2009 [accessed 05.02.10]
39. United Nations. The world economic and social survey: 2007 (2007). http://www.un.org/esa/policy/wess/ [accessed 05.02.10]